Main Text {#sec1}
=========

Proteins related to RNA metabolism account for ∼3%--11% coding capacity of the genome in all three domains of life, and RNA modifying enzymes are among the most conserved ones along with proteins involving transcription and translation ([@bib2]). RNA modifications require significant energy from the cell. For example, RNA methylation, a common modification, uses *S*-adenosylmethionine (SAM) as the methyl donor, and to produce one SAM molecule requires the energy equal to hydrolyzing 12 to 13 ATP molecules ([@bib4]). Given the significant cellular investment in RNA-modifying processes, RNA modifications are likely to be very important.

There are three main categories of RNA modifications: (1) modifications that enforce certain RNA structures and tune RNA biogenesis, such as modifications on rRNA and small nuclear RNA (snRNA) ([@bib23]); (2) modifications that expand the RNA vocabulary and refine molecular recognition, such as modifications at the decoding region in tRNA; and (3) modifications that code dynamic regulatory information on top of the primary sequence, such as modifications on mRNA. We will briefly summarize the first two categories and then focus primarily on the last category, because the idea that dynamic RNA modifications play active roles in gene regulation has been intensively studied in recent years. Finally, we will extend our discussion to future directions and technique developments in RNA modification research.

Ribosomal RNA Modifications {#sec1.1}
---------------------------

rRNA modifications are concentrated in functional regions such as peptidyl transferase center (PTC) ([@bib20]). In human ribosomal RNA, there are 91 pseudouridines (Ψ, [Figure 1](#fig1){ref-type="fig"} A), 105 2′-*O*-methylations on backbone sugars ([Figure 1](#fig1){ref-type="fig"}B), and ten methylated bases ([@bib63]). The biological effects of these modifications on rRNA have remained long-term puzzles. The prevailing hypothesis is that they fine-tune the structure and function of ribosome and perhaps play roles during ribosome biogenesis. Modified nucleotides possess distinctive chemical properties that could alter molecular interactions and conformations. For instance, 2′-*O*-methyl prevents hydrolysis of the phosphate backbone and causes the ribose sugar to favor the 3′ endo conformation ([@bib51]), and Ψ promotes base stacking ([@bib18]). Both modifications enhance the rigidity and stability of certain RNA secondary structures. While individual rRNA modifications seem to be dispensable, these modifications are vital when considered collectively ([@bib20]). For example, yeast strains with deficiency in rRNA modifications at PTC showed changes in tRNA selection, altered peptidyl transfer rates, reduced translation fidelity, and sensitivity to translation inhibitors ([@bib5]). Therefore, rRNA modifications around PTC are critical for translation accuracy and efficiency of the ribosome, but the exact structural and functional roles still require further investigation.Figure 1Chemical Structures of Selected RNA ModificationsChemical structures of selected RNA modifications.

Transfer RNA Modifications {#sec1.2}
--------------------------

tRNAs are the most heavily modified types of RNA. Approximately 15%--25% of all nucleosides in eukaryotic tRNA contain modifications ([@bib29]). These modifications have been proposed to serve various purposes ([@bib44]): (1) tRNA discrimination (e.g., initiator tRNA^Met^ is distinguished from elongator tRNA^Met^ through ribosylation at A~64~) ([@bib73]) ([Figure 1](#fig1){ref-type="fig"}C); (2) translation fidelity, where absence of inosine (I, resulting from deamination of A, [Figure 1](#fig1){ref-type="fig"}D) at wobble position 34 causes decoding errors because A only pairs with U while I extends codon-anticodon interaction capability through base pairing with U, A, and C ([@bib35]); and (3) tRNA stability (e.g., m^1^A~58~ of tRNA~i~ ^Met^ is required for tRNA stability) ([@bib3]) ([Figure 1](#fig1){ref-type="fig"}E).

Recent studies in yeast revealed that certain tRNA modifications can be quite dynamic and adaptive to environment changes. With a highly accurate mass spectroscopic method, it was shown that the spectrum of tRNA modification has signature shift upon exposure to different toxins ([@bib13]). In response to oxidative stress induced by hydrogen peroxide, the C~34~ at the wobble position (the first residue in the anticodon region) of yeast tRNA^Leu^ ~[C]{.ul}AA~ is modified by tRNA methyltranfserase 4 (Trm4). The m^5^C-modified tRNA^Leu^ ~CAA~ enhances the translation of UUG-rich transcripts ([@bib14]) ([Figure 1](#fig1){ref-type="fig"}F). The m^5^C level on tRNA^His^ (also catalyzed by Trm4) rises in response to nutrient depletion and other growth arrest conditions ([@bib65]). Another yeast tRNA methyltranfsrase, Trm9, completes the formation of mcm^5^U and mcm^5^s^2^U ([Figure 1](#fig1){ref-type="fig"}G) at the wobble U~34~ of tRNA^Arg^ ~UCU~ and tRNA^Glu^ ~[U]{.ul}UC~; this methylation prevents cell death by promoting translation of DNA damage response genes that are enriched with arginine and glutamic acid codons ([@bib6]). Besides methylation, a tRNA isopentenyltransferase enzyme Mod5 catalyzes the formation of *N* ^*6*^-isopentenyladeosine (i^6^A~37~) at A~37~ using dimethylally pyrophosphate. This i^6^A modification is required for tRNA-mediated nonsense suppression (recognition of a premature stop codon by mutant tRNA^Tyr^ to suppress protein truncation). In parallel, Erg20 utilizes the same substrate, dimethylally pyrophosphate, to produce an essential precursor of sterols, farnesyl pyrophosphate. Therefore, Mod5 and Erg20 compete for their common substrate. Overexpression of Erg20 elevates the influx of the common substrate to sterol pathway, reducing formation of i^6^A in tRNA^Tyr^, thereby changing translation due to altered nonsense suppression ([@bib7]). The coupling of tRNA modification and sterol biogenesis was further strengthened by the discovery that Mod5 can regulate sterol metabolic pathway via a prion state ([@bib75]). Besides enzymatic function, some tRNA modifying enzymes, such as tRNA pesudouridylases TruB, can also function as tRNA chaperone to facilitate maturation of tRNA ([@bib37]).

A mammalian DNA methyltransferase (DNMT), DNMT2, has been shown to actually work on tRNA cytosine methylation ([@bib36]). Several studies on the *Drosophila* homolog of DNMT2 showed that the DNMT2-mediated methylation protects tRNA against stress-induced fragmentation, which is beneficial because tRNA fragments can inhibit the activity of the small RNA processing enzyme Dicer-2 and cause dysfunction of RNA interference ([@bib68], [@bib27]). Dynamic tRNA modifications could directly impact codon selection and the outcome of translation. This is a rich and vibrant research field that should continue to generate surprising discoveries.

mRNA Modifications {#sec1.3}
------------------

mRNA plays a central role in the transduction of biological information from DNA to protein. Because mRNAs encode genetic information, most mRNA modifications need to be nonmutagenic and should not interfere with translation machinery. Therefore, most nucleoside modifications on mRNA are methylations, which minimally perturb the mRNA. There are four primary sites of methylation: *N* ^*7*^-methylguanine (m^7^G at the 5′ cap), *N* ^*6*^-methyl adenosine (m^6^A), 5-methylcytosine (m^5^C), and 2′-*O*-methylation of ribose ([Figure 1](#fig1){ref-type="fig"}). The cap structure has diverse functions; it promotes splicing, regulates mRNA nuclear export, and prevents 5′-3′degradation, and it is crucial during translation initiation, where it is recognized by cap-binding proteins ([@bib16], [@bib77]) and also suppresses aberrant translation ([@bib62]). While the cap is clearly important, we will focus our discussions on internal (non-cap) mRNA modifications.

### Reversible m^6^A Methylation {#sec1.3.1}

The m^6^A methylation is the most prevalent internal modification on eukaryotic mRNA. It was initially discovered in 1974, together with 5′ cap methylation ([@bib21], [@bib22]). However, progress on m^6^A research lagged far behind that of the cap, probably because of the low abundance of mRNA and difficulties in detection. Early studies showed that on average every mammalian mRNA contains three to five m^6^A within a G(m^6^A)C (70%) or A(m^6^A)C (30%) consensus sequence ([@bib84], [@bib83]), but the methylation percentage at each site varies substantially ([@bib48], [@bib12]). m^6^A is posttranscriptionally installed by an m^6^A methyltransferase complex ([@bib78], [@bib9]). The identification of a SAM-binding subunit (METTL3) of the complex ([@bib10]) allowed scientists to examine m^6^A in model organisms. The resulting work showed that m^6^A is crucial for yeast meiosis ([@bib72], [@bib15], [@bib70]), and for fruit fly ([@bib43]) and plant development ([@bib89]). The m^6^A methylation also appears to be essential for mammalian cells ([@bib8]).

In the last 4 years, the field has witnessed a major revival focusing on functional roles of m^6^A in eukaryotic mRNA ([@bib33]), initiated by (1) a conceptual conjecture that reversible RNA modification might serve regulatory roles analogous to DNA and histone epigenetic modifications ([@bib40], [@bib85]), followed by the subsequent discovery of the first mRNA demethylase FTO (fat mass and obesity-associated protein) that reverses m^6^A modification ([@bib46]); (2) the development of an antibody-based high-throughput m^6^A profiling method, m^6^A-seq ([@bib26]) or MeIP-seq ([@bib61], [@bib60]); and (3) the discovery and characterization of selective m^6^A-binding proteins that impact the stability of mRNA ([@bib26], [@bib81]). As a reversible mark analogous to methylations on DNA and histone tails, m^6^A on mRNA is installed, erased, and recognized by m^6^A methyltransferase, demethylase, and m^6^A-specific binding proteins. We have recently shown that METTL3 forms a stable heterodimer with METTL14 as the enzymatic core of the m^6^A methyltransferase complex and biochemically reconstituted their methylation activity ([@bib58], [@bib82]). In addition, the heterodimer also interacts with a splicing regulator, WTAP, which affects the m^6^A level inside cells ([@bib58], [@bib64]). The interaction between WTAP and m^6^A methyltransferase is also conserved in yeast ([@bib1]) and plants ([@bib89]). Early studies indicated that a large protein complex (200 kDa + 800 kDa) mediates this methylation ([@bib78], [@bib9]), hence other important protein factors surrounding the enzymatic core remain to be identified. Only a fraction of the all consensus sequences in mammalian mRNA are methylated. The methylation selectivity and its response to various cellular signals and stimuli remain to be elucidated in the future.

Functional understanding of m^6^A has lagged in part because of limited research on potential reader proteins that can selectively bind the methylated transcripts and mediate biological functions. Potential candidate proteins have been reported in RNA-affinity pull-down experiments using methylated RNA probes ([@bib26]). Three members of human YTH domain family proteins (YTHDF1--3) exhibit 5- to 20-fold higher binding affinity for methylated RNAs compared to unmethylated RNA ([@bib81]). In particular, YTHDF2 has been shown to affect the stability of m^6^A-containing RNA and localize the methylated mRNA from translatable pool to mRNA decay sites, such as processing bodies in parallel or at a later stage of deadenylation ([@bib81]). Interestingly, m^6^A-containing transcripts are enriched with regulatory genes (transcription factors, etc.) and inherently possess shorter half-live than nonmethylated species ([@bib33]), suggesting that the m^6^A-dependent mRNA turnover serves as a mechanism to dynamically affect expression of these genes ([@bib80]). The m^6^A methylation has been shown to affect stability of transcriptional regulators in mouse embryonic stem cells ([@bib82]), and two recent studies on yeast further support the notion that one main function of m^6^A is likely to affect transcript stability. Mmi1 in fission yeast is homologous to human YTH domain-containing proteins and is responsible for selectively eliminating meiotic mRNA transcripts during vegetative growth ([@bib39], [@bib41]). Ydr374c (Pho92 or MRB1), the YTH domain homolog in budding yeast, binds the m^6^A-containing RNA and seems to regulate the transcript stability of a key gene involved in phosphate signal transduction pathway in response to changing phosphate levels by interacting with the Pop2-Ccr4-Not deadenylation complex ([@bib49]).

The two recently discovered m^6^A demethylases (FTO and AlkBH5) have distinct physiological functions: *FTO* is associated with body weight and human diseases ([@bib24], [@bib30], [@bib25], [@bib42], [@bib52]), while the *Alkbh5* knockout mice have impaired fertility ([@bib88]), demonstrating functional impacts of the removal of m^6^A and importance of a delicate balance of the m^6^A methylation/demethylation activities in mammals. As the functional roles of m^6^A become defined, the mechanisms of the demethylation-based regulation will likely follow.

The abundant m^6^A methylation represents a different regulatory mechanism on top of the primary transcript sequence ([Figure 2](#fig2){ref-type="fig"} ). The discovery and functional elucidation of the writers, erasers, and readers of m^6^A will continue to reveal functional significance of this methylation. The writer proteins selectively install and set the code of the entire transcriptome at the upstream of information processing. Demethylases balance the methylation stoichiometry of specific mRNAs, perhaps in a pathway- and cell-type-specific manner. The m^6^A "reader" proteins are at the end of information processing, executing the biological functions of m^6^A on specific transcripts through rapid and localized reading of the m^6^A mark. Protein of all three stages can couple with signal transduction pathways via protein-protein interaction or posttranslational modifications, which provide a dynamic and rapid response to cellular signals, environmental stimuli, or programmed biological transformations.Figure 2Reversible m^6^A Modification Affects Gene Expression Regulation in Mammalian CellsThe m^6^A writer proteins install the m^6^A code on the transcriptome in coordination with RNA splicing and processing. The METTL3-METTL14 heterodimer is the enzymatic core of the m^6^A writer complex, while WTAP and other factors could regulate the methylation process. The m^6^A eraser proteins (FTO and AlkBH5) further tune the methylation stoichiometry, perhaps in a more pathway-specific manner. The m^6^A reader proteins (e.g., YTHDF family proteins) recognize the m^6^A code and execute biological functions. YTHDF2 promotes the decay of the m^6^A-containing RNA while other reader proteins could potentially affect the translation, storage, or nuclear export of methylated RNA. All these proteins could couple their functions with cellular signaling pathways, responses to environmental stimuli, or programmed biological transformations. *S*-adenosyl methionine (SAM) is the cofactor of METTL3-METTL14 with *S*-adenosyl homocysteine (SAH) as the product after the methylation. α-ketoglutarate (α-KG) is the cofactor of FTO and AlkBH5 with succinate as the product.

### m^5^C {#sec1.3.2}

5-Methylcytosine is a well-known epigenetic modification in eukaryotic genomic DNA and is known to exist in rRNA and tRNA; however, recent transcriptome-wide mapping of m^5^C in human RNA has uncovered over ten thousand candidate m^5^C sites in mRNA and other noncoding RNAs ([@bib74]). In mRNA, these sites are enriched in untranslated regions and around Argonaute binding sites. By using both bisulfite sequencing and immunoprecipitation with anti-m^5^C antibody followed by sequencing, 14 m^5^C sites were verified in archaeal (*S. solfataricus*) mRNA with a consensus motif of AU(m^5^C)GANGU, similar to the m^5^C sites on *S. solfataricus* rRNA, suggesting a shared m^5^C methyltransferase in the deposition of m^5^C ([@bib28]). Several genes bearing m^5^C are enzymes involved in energy and lipid metabolism, possibly indicating a regulatory role of m^5^C in metabolic processes. Several m^5^C methyltransferases that were thought to work on rRNA and tRNA have binding sites on mRNA, suggesting additional roles that impact mRNA ([@bib87], [@bib53], [@bib45]).

### 2′-O-Methylation {#sec1.3.3}

2′-*O*-methylation is involved in discrimination of self and nonself mRNA ([@bib17]). Human and mouse coronavirus mutants lacking 2′-*O*-methyltransferase activity triggered higher level of type I interferon via the recognition of Mda5, a cytoplasmic protein that senses double-stranded RNA ([@bib90]). Hence, it is not surprising that 2′-*O*-methylation has been widely incorporated into small interference RNA (siRNA) to optimize the stability and immunogenic properties of siRNA ([@bib47]). Plant microRNAs (miRNA) bear naturally occurring 2′-*O*-methylation installed by a methyltransferase HEN1 ([@bib86]). The function of such a modification is suggested to protect the 3′ end of miRNA against polyuridylation, thus preventing miRNA from poly(U)-mediated degradation ([@bib56]).

### Pseudouridine {#sec1.3.4}

Pseudourindine, "the fifth base," was the first known modification, discovered over 60 years ago ([@bib19]) ([Figure 1](#fig1){ref-type="fig"}A). Pseudouridine modification provides an additional hydrogen-bonding donor that can significantly affect the secondary structure of RNA. Its presence on mRNA could impact translation by affecting the secondary structures of mRNA or recruiting potential reader proteins. A recent inspiring work showed that replacing the first uridine of the stop codon to psedourindine can convert nonsense (stop) codon to sense codon, thus raising the possibility of expanding the genetic codon or recoding transcripts by introducing RNA modifications on mRNA ([@bib50]). More recently, transcriptome-wide mapping has uncovered hundreds of naturally occurring psedourindine sites in yeast and human mRNA. These pseudouridine sites are responsive to nutrition starvation and heat shock ([@bib11], [@bib71]), suggesting mRNA pseudouridylation as a potential mechanism to rapidly adapt the translation landscape to environmental stress.

Modifications of Other Noncoding RNAs {#sec1.4}
-------------------------------------

Long noncoding RNAs (lncRNAs) are known to have diverse roles in chromatin remodeling, transcription, and mRNA processing ([@bib59], [@bib66], [@bib55]). It has been shown that some lncRNAs, such as MALAT1, TUG1, and NEAT1, contain multiple m^6^A sites ([@bib26], [@bib61], [@bib57]). The roles and potential reversibility of these m^6^A sites on lncRNAs are still unclear. Another major class of noncoding RNAs are the U snRNAs as the well-established RNA components of the spliceosome (U1, U2, U4, U5, and U6, etc.). The 5′-terminal capping is essential to the exportation of U snRNAs to cytoplasm from nucleus ([@bib23]). snRNAs also contain internal modifications such as Ψ, 2′-*O*-methylation, and m^6^A. It is unclear if these modifications are dynamic, and their functional roles remain to be fully elucidated.

Prospects {#sec1.5}
---------

We propose several emerging themes in the rapidly developing field of RNA modifications.

### Identifying and Characterizing RNA Modifying/Demodifying Enzymes and Binding Proteins {#sec1.5.1}

The discovery of the first mRNA demethylase FTO stimulated the study of reversible RNA modifications. Much needs to be done to understand factors like FTO and others that have already been identified. Indeed, important questions remain. For example, how does the writer complex achieve selectivity? And how does the function of the writer complex relate to transcription and splicing?

Beyond the known factors, it is likely other writer, easer, and reader proteins for the RNA m^6^A methylation exist. Identifying and characterizing these proteins, present in either the cytoplasm or nucleus, will be critical for understanding and expanding the biological roles of m^6^A. We know that m^6^A affects mRNA stability through the YTHDF2-mediated decay pathway ([@bib81], [@bib80]), but other proteins might read m^6^A differently, leading to effects on RNA transport, storage, and translation in response to signals and cellular stress.

Other RNA modifications might be written and erased like m^6^A. If they are, the SAM-binding methyltransferases and α-KG-dependent dioxygenases (including AlkB family that FTO and AlkBH5 belong to) are promising groups of methyltransferases and demethylases worth studying. The methyl group of m^6^A can be further oxidized to *N* ^*6*^-hydroxymethyladenosine (hm^6^A) and *N* ^*6*^-formyladenosine (f^6^A) in vitro and in vivo ([@bib32]), and future work should establish the functional importance of these changes.

### Reversible Modifications on tRNA, rRNA, and Other Noncoding RNAs {#sec1.5.2}

In 2010, when we proposed reversible RNA modification, or "RNA epigenetics," as a means to effect genetic information akin to DNA and histone modifications. Reversible methylation, as recently discovered, may not be restricted to mRNA. tRNA, rRNA, and other noncoding RNAs could also be targets for methylation and demethylation ([Figure 3](#fig3){ref-type="fig"} ). Indeed, pri-microRNAs and lncRNA are known to contain m^6^A ([@bib26], [@bib57]), which might be reversible and affect their cellular localization and functions.Figure 3Dynamic RNA Modifications in Gene Expression RegulationRNA modifications in various RNA species (rRNA, mRNA, tRNA, lncRNA, and miRNA) could be reversible and play active roles in regulating transcription and posttranscriptional gene expression.

tRNA and rRNA are enriched with diverse chemical modifications, including various methylations. Reversible modifications on rRNA could affect biogenesis of rRNA and functions of ribosome. On tRNA, reversible modifications could rapidly and broadly impact cellular protein production. We know that tRNA methylation can be quite dynamic in mammalian cells ([@bib13], [@bib67], [@bib31]). It will be hard to believe the simple reversible methylation chemistry, already known to occur on mRNA, is not harnessed by nature via evolution to directly affect translation through tRNA and/or rRNA. Additional discoveries and future research in these directions could reveal new mechanisms of biological regulation.

### Elucidating the Functions of RNA Modification in Dynamic Biological Processes {#sec1.5.3}

In contrast to regulatory information encoded by the primary sequence, reversible RNA modification is dynamic and may affect biological processes involving major transformations of cell states, such as gametogenesis, embryonic development, neuronal differentiation, and immune responses, without affecting the coding sequence. For example, m^6^A has been suggested to act as a pacesetter of the mammalian circadian clock ([@bib34]) and a switch for yeast meiotic entrance ([@bib72], [@bib1]). As discussed above, various RNA modifications are responsive to changes in nutrient and metabolite levels, probably because the modifications require energy to produce and because cofactors like SAM, iron, and α-KG are shared by RNA-modifying enzymes and metabolic enzymes ([Figure 2](#fig2){ref-type="fig"}). We expect that future studies will reveal further connections between RNA modifications and cell metabolism, and they may connect RNA modifications to human diseases like cancer, in part, through effects on metabolism. Because the functions of mRNA, rRNA, and tRNA directly connect to translation, modifications on these RNA species could significantly determine the outcome of protein production, localized and general, to affect states of the cell in various contexts, such as localized translation in neurons.

The DNA and histone epigenetic modifications are not only reversible and affect gene expression regulation, but the effects can also be heritable. Could reversible RNA modification be heritable too? Several promising directions could be explored to address this question. RNA modification might be involved in maternal effect. At the early stage of embryo development, transcription is inactivated and protein expression is dominated by the translation of prestored maternal mRNA ([@bib76]). Therefore, any shift in the modification pattern of maternal mRNA would have a profound effect on zygotic development, and if such a change is remembered at the posttranscriptional or transcriptional level, it could be passed on to the next generation. Similarly, RNA modifications could mark different transcripts during meiosis and/or mitosis to affect transfer of inheritable information between generations.

### Detection Techniques {#sec1.5.4}

The lack of accurate and sensitive detection methods has limited the study of RNA modifications in low abundance RNA species (e.g., mRNA). Traditional techniques involve isotope labeling and lipid or thin-plate chromatography, which are tedious, semiquantitative, low-throughput, and require a large amount of starting materials. The recent developments in highly sensitive technologies have revolutionized research on RNA modifications, in particular on low-abundance RNA species. These developments include (1) liquid chromatography-tandem mass spectroscopy followed by mass fingerprinting (LC-MS/MS), which enables accurate quantification of modified nucleosides with unambiguous chemical identity with fmol (10^−15^) sensitivity, and (2) next-generation sequencing coupled with modification-specific antibodies, which enables transcriptome-wide profiling of RNA modification sites. While LC-MS/MS provides quantification for a population of RNA and sequencing qualitatively locates candidate modification sites, there has been a lack of a high-throughput method available to determine precise modification sites and the stoichiometry for each modification at those sites.

The study of m^5^C in DNA/RNA has greatly benefited from bisulfate sequencing capable of determining methylation percentage at each site. However, similar chemistry is not always available for other base modifications. For example, the dynamic m^6^A methylation is nonstoichiometric on mRNA, and the balance of methyltransferase/demethylase activities indeed has physiological consequences. So far, SCARLET (site-specific cleavage and radioactive labeling followed by ligation-assisted extraction and thin-layer chromatography) is the only reported method to directly determine the presence and fraction of m^6^A at single-nucleotide resolution ([@bib57]), but it is low-throughput. The use of m^6^A-sensitive reverse transcription enzymes to detect the kinetic delay or stall at the m^6^A site ([@bib79], [@bib38]) and the protein-modified nanopore sequencing ([@bib54], [@bib69]) might be promising, but they are still not ready to be used in real applications. A method that could detect modifications with limited input materials (e.g., RNA isolated from a single cell) is also lacking. The dynamics in each individual cell and effects on early developmental events of RNA modifications can be learned with new technologies. Since every RNA modification has its own unique biochemical/chemical property, the solution to efficiently detect and distinguish each of them remains challenging for chemists, biochemist, and biologists.

The development of in situ detection methods of RNA modification is another challenge. Fluorescence in situ hybridization is a main method used to visualize mRNA within cell or tissue specimen. For nonstoichiometric RNA modifications, RNA modification could impact spatial localization information among a heterogeneous population of target RNA. In order to fully reveal the biological functions of RNA modifications, it would be valuable to directly visualize and report the modification status on specific transcripts.

In summary, with modern technologies available, RNA modifications can be studied in a more quantitative manner. We propose that reversible RNA modifications occur in different RNA species and broadly influence gene expression as a previously unappreciated layer of posttranscriptional regulation.
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